NASDAQ : PASW
Ping An Biomedical Co., Ltd. — Key statistics
Consumer Discretionary · Textile Manufacturing · Hong Kong
Last price 5 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 15.64M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 16.01M |
| Enterprise Value | 16.51M |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 3.13M |
| Shares Outstanding | 3.13M |
| Shares Change (YoY) | +93.03% |
| Shares Change (QoQ) | +166.53% |
| Owned by Insiders (%) | 9.79% |
| Owned by Institutions (%) | 0.24% |
| Float | 1.87M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.33 |
| Forward PS | n/a |
| PB Ratio | 1.41 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 4.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.54 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.66 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -11.35% |
| Return on Assets (ROA) | -8.86% |
| Return on Invested Capital (ROIC) | -12.92% |
| Return on Capital Employed (ROCE) | -13.49% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $528,382 |
| Profits Per Employee | -$78,086 |
| Employee Count | 7 |
| Asset Turnover | 0.34 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -129,430 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -82.94% |
| 50-Day Moving Average | 5.15 |
| 200-Day Moving Average | 6.11 |
| Relative Strength Index (RSI) | 51.76 |
| Average Volume (20 Days) | 45,461 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 370,293 |
| Short Previous Month | 488,277 |
| Short % of Shares Out | 11.84% |
| Short % of Float | 19.84% |
| Short Ratio (days to cover) | 0.40 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.70M |
| Gross Profit | 342,909 |
| Operating Income | -1.53M |
| Pretax Income | -676,030 |
| Net Income | -546,599 |
| EBITDA | -1.53M |
| EBIT | -1.53M |
| Loss Per Share | -$0.63 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 992,023 |
| Total Debt | 1.49M |
| Net Cash | -497,366 |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 11.34M |
| Book Value Per Share | 3.62 |
| Working Capital | 4.91M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -833,231 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 736 |
| Net Borrowing | -5.36M |
| Free Cash Flow | -833,231 |
| FCF Per Share | -$0.27 |
Margins
| Measure | Value |
|---|
| Gross Margin | 9.27% |
| Operating Margin | -41.34% |
| Pretax Margin | -18.28% |
| Profit Margin | -14.78% |
| EBITDA Margin | -41.32% |
| EBIT Margin | -41.34% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -93.03% |
| Shareholder Yield | -93.03% |
| Earnings Yield | -12.29% |
| FCF Yield | -5.20% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 23, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.65 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |